Benzinga | Jan 28, 2022 09:15AM EST

Argus Research Upgrades Gilead Sciences to Buy, Announces $75 Price Target

Argus Research analyst David Toung upgrades Gilead Sciences (NASDAQ:GILD) from Hold to Buy and announces $75 price target.